BMES conference – Frontiers in Medical Devices
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine.
The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.
During the US trip to Washington, the Avicenna Alliance Delegation also actively participated in the BMES/FDA Frontiers in Medical Devices Conference co-sponsored by the Biomedical Engineering Society (BMES) and the FDA who formed a partnership to co-sponsor the 3rd annual BMES/FDA Frontiers in Medical Devices Conference, a meeting for researchers, engineers, clinicians and other professionals in the fields of designing, building and using medical devices.
The Conference theme for the 2017 meeting was Innovations in Modeling and Simulation: Advancing Translational Science which was meant to highlight exemplary applications of computational modeling and simulation from initial disease diagnosis through long-term follow-up and rehabilitation. The Avicenna Alliance had the opportunity to present and advertise its activities at the conference on why policy matters for business. The Avicenna Alliance also made good use of its booth at the conference which allowed to further promote the Alliance and VPH as not just 50% of the Alliance board but as a stand-alone institute for interested academic and research groups.
The main outcome of this day was the fact that the globally active medical devices manufacturer Boston Scientific joined the Avicenna Alliance as a Member.